Amgen, Inc. (AMGN) Stock Price Today
Aura AI Summary
Key Stats
- $198.67BMARKET_CAP
- -VOLUME
- HealthSECTOR
- $388.16FIFTY_TWO_WEEK_HIGH
- $271.18FIFTY_TWO_WEEK_LOW
- -TYPICAL_HOLD_TIME
- $243.95BENTERPRISE_VALUE
- 2.74%DIVIDEND_YIELD
- -TRADING_ACTIVITY
Track Amgen, Inc. (AMGN) stock price today on Pluang, updated in real time with live charts and market data. Over the past 52 weeks, Amgen, Inc. has traded between a low of $271.18 and a high of $388.16, highlighting its annual price range. Buy and sell Amgen, Inc. shares on Pluang with fractional shares and real-time market data — safe and OJK-regulated.
About Amgen, Inc.
Amgen is a leader in biotechnology-based human therapeutics, with historical expertise in renal disease and cancer supportive-care products. Flagship drugs include red blood cell boosters Epogen and Aranesp, immune system boosters Neupogen and Neulasta, and Enbrel and Otezla for inflammatory diseases. Amgen introduced its first cancer therapeutic, Vectibix, in 2006 and markets bone-strengthening drug Prolia/Xgeva (approved 2010) and Evenity (2019). The acquisition of Onyx bolstered the firm's therapeutic oncology portfolio with Kyprolis. Recent launches include Repatha (cholesterol-lowering), Aimovig (migraine), Lumakras (lung cancer), and Tezspire (asthma). Amgen's biosimilar portfolio includes Mvasi (biosimilar Avastin), Kanjinti (biosimilar Herceptin), and Amgevita (biosimilar Humira).
Most Recent News
Global golf simulators market to reach $5.5B by 2035 with 8.6% CAGR, driven by tech advances and rising home use
The global golf simulators market, valued at $2.4 billion in 2025, is projected to grow to $5.5 billion by 2035 at an 8.6% CAGR. Growth is fueled by technological improvements, increased commercial and residential use, and rising demand for indoor go...
Capital Power signs 10+ year deal to supply 250 MW to Meta's Alberta data centre by 2028
Capital Power Corporation has entered a long-term energy supply agreement to provide 250 megawatts of power to Meta's new data centre in Sturgeon County, Alberta, expected to be operational in late 2028. This deal strengthens Capital Power's position...
Class action lawsuit filed over Megan Holdings' alleged misleading IPO disclosures causing investor losses.
A securities class action lawsuit has been filed against Megan Holdings Limited by investors who purchased shares during its September 2025 IPO or between September 2025 and May 2026. The lawsuit alleges the company made false and misleading statemen...
